Probiotics for the treatment of eczema: A systematic review

Clinical and Experimental Allergy

Volumn 39, Issue 8, 2009, Pages 1117-1127

  Boyle, R J ^a,b,c   Bath Hextall, F J ^d   Leonardi Bee, J ^d   Murrell, D F ^e   Tang, M L K ^a,b,f  

^a MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^e ST GEORGE HOSPITAL   (Australia)

^f ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

Eczema; Meta analysis; Probiotic

Indexed keywords

PLACEBO; PROBIOTIC AGENT;

ARTICLE; ATOPY; CLINICAL TRIAL; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; ECZEMA; HUMAN; INTESTINE ISCHEMIA; META ANALYSIS; OUTCOMES RESEARCH; PRIORITY JOURNAL; QUALITY OF LIFE; SEPSIS; STRAIN DIFFERENCE; SYMPTOMATOLOGY; SYSTEMATIC REVIEW; TREATMENT CONTRAINDICATION;

ECZEMA; HUMANS; PLACEBOS; PROBIOTICS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 67650436138     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2009.03305.x     Document Type: Article

References (60)

1. Williams H, Robertson C, Stewart A et al. Worldwide variations in the prevalence of symptoms of atopic eczema in the International Study of Asthma and Allergies in Childhood. J Allergy Clin Immunol 1999 103 : 125 38.
2. Charman C, Williams H. Epidemiology. In : Bieber T, Leung D, eds. Atopic dermatitis. New York : Marcel Dekker Inc, 2002 21 42.
3. Su JC, Kemp AS, Varigos GA, Nolan TM. Atopic eczema: its impact on the family and financial cost. Arch Dis Child 1997 76 : 159 62.
4. Kemp AS. Atopic eczema: its social and financial costs. J Paediatr Child Health 1999 35 : 229 31.
5. Ellis CN, Drake LA, Prendergast MM et al. Cost of atopic dermatitis and eczema in the United States. J Am Acad Dermatol 2002 46 : 361 70.
6. Hoare C, Li Wan Po A, Williams H. Systematic review of treatments for atopic eczema. Health Technol Assess 2000 4 : 1 191.
7. Bjorksten B, Sepp E, Julge K, Voor T, Mikelsaar M. Allergy development and the intestinal microflora during the first year of life. J Allergy Clin Immunol 2001 108 : 516 20.
8. Kalliomaki M, Kirjavainen P, Eerola E, Kero P, Salminen S, Isolauri E. Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing. J Allergy Clin Immunol 2001 107 : 129 34.
9. Murray CS, Tannock GW, Simon MA et al. Fecal microbiota in sensitized wheezy and non-sensitized non-wheezy children: a nested case-control study. Clin Exp Allergy 2005 35 : 741 5.
10. Penders J, Thijs C, van den Brandt PA et al. Gut microbiota composition and development of atopic manifestations in infancy: the KOALA Birth Cohort Study. Gut 2007 56 : 661 7.
11. Wang M, Karlsson C, Olsson C et al. Reduced diversity in the early fecal microbiota of infants with atopic eczema. J Allergy Clin Immunol 2008 121 : 129 34.
12. FAO/WHO. Guidelines for the evaluation of probiotics in food. London : FAO/WHO, 2002.
13. Allen SJ, Okoko B, Martinez E, Gregorio G, Dans LF. Probiotics for treating infectious diarrhoea. Cochrane Database Syst Rev 2003 4 : CD003048.
14. Gionchetti P, Rizzello F, Venturi A et al. Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. Gastroenterology 2000 119 : 305 9.
15. Pessi T, Sutas Y, Hurme M, Isolauri E. Interleukin-10 generation in atopic children following oral Lactobacillus rhamnosus GG. Clin Exp Allergy 2000 30 : 1804 8.
16. Rosenfeldt V, Benfeldt E, Valerius NH, Paerregaard A, Michaelsen KF. Effect of probiotics on gastrointestinal symptoms and small intestinal permeability in children with atopic dermatitis. J Pediatr 2004 145 : 612 6.
17. Sepp E, Mikelsaar M, Salminen S. Effect of Lactobacillus casei strain GG administration on the gastrointestinal microbiota of newborns. Microb Ecol Health Dis 1993 6 : 309 14.
18. Spanhaak S, Havenaar R, Schaafsma G. The effect of consumption of milk fermented by Lactobacillus casei strain Shirota on the intestinal microflora and immune parameters in humans. Eur J Clin Nutr 1998 52 : 899 907. (Pubitemid 29008371)
19. Christensen HR, Frokiaer H, Pestka JJ. Lactobacilli differentially modulate expression of cytokines and maturation surface markers in murine dendritic cells. J Immunol 2002 168 : 171 8.
20. Higgins JP, Green S. The Cochrane handbook for systematic reviews of interventions version 5.0.0. The Cochrane Collaboration, 2008. Available at
21. Boyle RJ, Bath-Hexall F, Murrell D, Leonardi-Bee J, Tang ML-K. Probiotics for treating eczema. Cochrane Database Syst Rev 2008 (4) : CD006135.
22. Rosenfeldt V, Benfeldt E, Nielsen SD et al. Effect of probiotic Lactobacillus strains in children with atopic dermatitis. J Allergy Clin Immunol 2003 111 : 389 95.
23. Gruber C, Wendt M, Sulser C et al. Randomized, placebo-controlled trial of Lactobacillus rhamnosus GG as treatment of atopic dermatitis in infancy. Allergy 2007 62 : 1270 6.
24. Sistek D, Kelly R, Wickens K, Stanley T, Fitzharris P, Crane J. Is the effect of probiotics on atopic dermatitis confined to food sensitized children? Clin Exp Allergy 2006 36 : 629 33.
25. Weston S, Halbert AR, Richmond P, Prescott SL. Effects of probiotics on atopic dermatitis: a randomised controlled trial. Arch Dis Child 2005 90 : 892 7.
26. Kunz B, Oranje AP, Labreze L, Stalder JF, Ring J, Taieb A. Clinical validation and guidelines for the SCORAD index: consensus report of the European Task Force on Atopic Dermatitis. Dermatology 1997 195 : 10 9.
27. Folster-Holst R, Muller F, Schnopp N et al. Prospective, randomized controlled trial on Lactobacillus rhamnosus in infants with moderate to severe atopic dermatitis. Br J Dermatol 2006 155 : 1256 61.
28. Isolauri E, Arvola T, Sutas Y, Moilanen E, Salminen S. Probiotics in the management of atopic eczema. Clin Exp Allergy 2000 30 : 1604 10.
29. Brouwer ML, Wolt-Plompen SA, Dubois AE et al. No effects of probiotics on atopic dermatitis in infancy: a randomized placebo-controlled trial. Clin Exp Allergy 2006 36 : 899 906. (Pubitemid 43972956)
30. Hattori K, Yamamoto A, Sasai M et al. Effects of administration of bifidobacteria on fecal microflora and clinical symptoms in infants with atopic dermatitis. Arerugi 2003 52 : 20 30. (Pubitemid 36305959)
31. Kirjavainen PV, Salminen SJ, Isolauri E. Probiotic bacteria in the management of atopic disease: underscoring the importance of viability. J Pediatr Gastroenterol Nutr 2003 36 : 223 7.
32. Majamaa H, Isolauri E. Probiotics: a novel approach in the management of food allergy. J Allergy Clin Immunol 1997 99 : 179 85.
33. Passeron T, Lacour JP, Fontas E, Ortonne JP. Prebiotics and synbiotics: two promising approaches for the treatment of atopic dermatitis in children above 2 years. Allergy 2006 61 : 431 7.
34. Viljanen M, Savilahti E, Haahtela T et al. Probiotics in the treatment of atopic eczema/dermatitis syndrome in infants: a double-blind placebo-controlled trial. Allergy 2005 60 : 494 500. (Pubitemid 40332976)
35. The Cochrane Collaboration. Review Manager [RevMan] version 5.0. Copenhagen : The Nordic Cochrane Centre, The Cochrane Collaboration, 2008.
36. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002 21 : 1539 58.
37. Boyle RJ, Bath-Hextall F, Donath S et al. Probiotics for atopic eczema (Protocol). Cochrane Database Syst Rev 2006 : CD006135.
38. Cherifi S, Robberecht J, Miendje Y. Saccharomyces cerevisiae fungemia in an elderly patient with Clostridium difficile colitis. Acta Clin Belg 2004 59 : 223 4.
39. De Groote MA, Frank DN, Dowell E, Glode MP, Pace NR. Lactobacillus rhamnosus GG bacteremia associated with probiotic use in a child with short gut syndrome. Pediatr Infect Dis J 2005 24 : 278 80.
40. Lestin F, Pertschy A, Rimek D. Fungemia after oral treatment with Saccharomyces boulardii in a patient with multiple comorbidities. Dtsch Med Wochenschr 2003 128 : 2531 3.
41. Riquelme AJ, Calvo MA, Guzman AM et al. Saccharomyces cerevisiae fungemia after Saccharomyces boulardii treatment in immunocompromised patients. J Clin Gastroenterol 2003 36 : 41 3.
42. Boyle RJ, Robins-Browne RM, Tang ML. Probiotic use in clinical practice: what are the risks? Am J Clin Nutr 2006 83 : 1256 64.
43. Ishibashi N, Yamazaki S. Probiotics and safety. Am J Clin Nutr 2001 73 : 465S 70S.
44. Besselink MG, van Santvoort HC, Buskens E et al. Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial. Lancet 2008 371 : 651 9.
45. Breuer K, Braeutigam M, Kapp A, Werfel T. Influence of pimecrolimus cream 1% on different morphological signs of eczema in infants with atopic dermatitis. Dermatology 2004 209 : 314 20.
46. Lee J, Seto D, Bielory L. Meta-analysis of clinical trials of probiotics for prevention and treatment of pediatric atopic dermatitis. J Allergy Clin Immunol 2008 121 : 116 21.
47. Boyle RJ, Leonardi-Bee J, Bath-Hextall FJ, Tang ML. Probiotics for the treatment or prevention of eczema. J Allergy Clin Immunol 2009 123 : 266 7.
48. Michail SK, Stolfi A, Johnson T, Onady GM. Efficacy of probiotics in the treatment of pediatric atopic dermatitis: a meta-analysis of randomized controlled trials. Ann Allergy Asthma Immunol 2008 101 : 508 16.
49. Collier A, Heilig L, Schilling L, Williams H, Dellavalle RP. Cochrane Skin Group systematic reviews are more methodologically rigorous than other systematic reviews in dermatology. Br J Dermatol 2006 155 : 1230 5.
50. Jorgensen AW, Hilden J, Gotzsche PC. Cochrane reviews compared with industry supported meta-analyses and other meta-analyses of the same drugs: systematic review. BMJ 2006 333 : 782.
51. Alfaleh K, Bassler D. Probiotics for prevention of necrotizing enterocolitis in preterm infants. Cochrane Database Syst Rev 2008 : CD005496.
52. Werfel T, Breuer K. Role of food allergy in atopic dermatitis. Curr Opin Allergy Clin Immunol 2004 4 : 379 85.
53. Caffarelli C, Cavagni G, Deriu FM, Zanotti P, Atherton DJ. Gastrointestinal symptoms in atopic eczema. Arch Dis Child 1998 78 : 230 4.
54. Kelly D, Campbell JI, King TP et al. Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-gamma and RelA. Nat Immunol 2004 5 : 104 12.
55. Neish AS, Gewirtz AT, Zeng H et al. Prokaryotic regulation of epithelial responses by inhibition of IkappaB-alpha ubiquitination. Science 2000 289 : 1560 3.
56. Abrahamsson TR, Jakobsson T, Bottcher MF et al. Probiotics in prevention of IgE-associated eczema: a double-blind, randomized, placebo-controlled trial. J Allergy Clin Immunol 2007 119 : 1174 80.
57. Kukkonen K, Savilahti E, Haahtela T et al. Probiotics and prebiotic galacto-oligosaccharides in the prevention of allergic diseases: a randomized, double-blind, placebo-controlled trial. J Allergy Clin Immunol 2007 119 : 192 8.
58. Osborn DA, Sinn JK. Probiotics in infants for prevention of allergic disease and food hypersensitivity. Cochrane Database Syst Rev 2007 : CD006475.
59. Kopp MV, Hennemuth I, Heinzmann A, Urbanek R. Randomized, double-blind, placebo-controlled trial of probiotics for primary prevention: no clinical effects of Lactobacillus GG supplementation. Pediatrics 2008 121 : e850 6.
60. Taylor AL, Dunstan JA, Prescott SL. Probiotic supplementation for the first 6 months of life fails to reduce the risk of atopic dermatitis and increases the risk of allergen sensitization in high-risk children: a randomized controlled trial. J Allergy Clin Immunol 2007 119 : 184 91.